Stocktoria
Coya Therapeutics, Inc. COYA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-12-29
Chart by TradingView
2/9
Piotroski F — financial health
5.24
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $7.9M | $3.6M | $6.0M | $0 | — |
| Operating income | -$22.6M | -$17.2M | -$7.9M | -$9.8M | -$4.9M |
| Net income | -$21.2M | -$14.9M | -$8.0M | -$12.2M | -$4.9M |
| Operating cash flow | -$10.7M | -$10.3M | -$11.2M | -$7.2M | -$3.9M |
| Total assets | $50.0M | $44.3M | $41.3M | $8.4M | $4.8M |
| Total liabilities | $6.9M | $4.8M | $5.6M | $16.8M | $1.1M |
| Shareholders' equity | $43.0M | $39.6M | $35.6M | -$8.4M | $3.6M |
| Ratios | |||||
| Operating margin | -283.9% | -485.4% | -131.7% | — | — |
| Net margin | -267.1% | -418.7% | -133.1% | — | — |
| Return on assets | -42.5% | -33.6% | -19.4% | -145.8% | -102.1% |
| Return on equity | -49.3% | -37.6% | -22.4% | 145.9% | -134.3% |
| Current ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 |
| Revenue growth | 123.6% | -40.8% | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| GREENLIGHT CAPITAL INC | 1,274,026 | $9.4M |
| RENAISSANCE TECHNOLOGIES LLC | 103,964 | $409,618 |
| Point72 Asset Management, L.P. | 37,681 | $148,463 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.24 (safe)
- Working capital / assets 0.882
- Retained earnings / assets -1.24
- EBIT / assets -0.452
- Equity / liabilities 6.216
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001835022 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.